Ezogabine
Back to searchMolecule Structure
Scientific Name
Ezogabine
Description of the Drug
Ezogabine is an antiepileptic agent used as an adjuvant treatment of partial-onset seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB04953
http://www.drugbank.ca/drugs/DB04953
Brand Name(s)
Potiga, Trobalt
Company Owner(s)
Glaxosmithkline
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| KCNQ (Kv7) potassium channel | PROTEIN FAMILY | OPENER | CHEMBL2363063 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL20835 |
| Human Metabolome Database | HMDB0257171 |
| DrugBank | DB04953 |
| PubChem: Thomson Pharma | 14800601 |
| PubChem | 121892 |
| LINCS | LSM-45405 |
| Nikkaji | J751.646K |
| PDBe | FBX |
| BindingDB | 50143558 |
| EPA CompTox Dashboard | DTXSID40164615 |
| DrugCentral | 4181 |
| Brenda | 8844 |
| ChemicalBook | CB7506804 |
| Guide to Pharmacology | 2601 |
| rxnorm | EZOGABINE |
| PubChem: Drugs of the Future | 12015005 |
| KEGG Ligand | C13826 |
| ChEBI | 68584 |
| ZINC | ZINC000000016154 |
